Glycine Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Glycine dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Glycine.
Dosing Protocols
Beginner Protocol (foundational support and sleep):
Week 1-2 (introduction):
- Start with 3 g glycine powder (approximately 3/4 teaspoon) mixed in water 30-60 minutes before bedtime.
- Alternatively, take 3 g with dinner if evening digestion works better for you.
- Monitor for subjective sleep quality changes, dream vividness, morning alertness.
- Note baseline: typical sleep latency, quality of sleep, daytime energy.
Week 3-6 (titration):
- If tolerating well and wanting more effect, increase to 5 g at bedtime.
- Alternatively, add a morning 3 g dose (total 6-8 g daily) if using glycine for broader longevity/glutathione support.
- Continue monitoring subjective outcomes.
- Taste: glycine is naturally sweet, so mixing in water is usually pleasant; can also add to herbal tea (not hot enough to degrade—glycine is actually stable to boiling).
Month 2-3 (maintenance):
- Most users settle at 3-10 g daily total based on goals:
- Sleep focus: 3-5 g at bedtime
- Broader wellness: 5-8 g daily (split morning/evening)
- Longevity focus: 8-10 g daily (consider adding NAC per GlyNAC protocol)
Specific starter scenarios:
For occasional insomnia or sleep quality improvement:
- Glycine 3 g powder in water 30-60 minutes before bedtime
- Continue 2-4 weeks to assess effect
- Many users notice improvement within first few nights
For general wellness and aging support:
- Glycine 5 g daily (split morning/evening or single dose)
- Consider adding NAC 600-1200 mg daily for GlyNAC effect
- 3-6 month trial for biomarker assessment
For connective tissue support (skin, joints, recovery):
- Glycine 5-10 g daily
- Combine with collagen peptides 10-20 g daily
- Add vitamin C 500 mg for collagen synthesis support
- 3-month trial for subjective results
For glycemic support adjunctive to dietary/exercise changes:
- Glycine 5 g with largest meals (2 times daily, total 10 g)
- Track fasting glucose and HbA1c baseline and 3-month
- Not a replacement for prescribed diabetes medications
For dietary insufficiency (vegetarian, elderly with low meat intake):
- Glycine 3-5 g daily to compensate for lower dietary collagen/connective tissue intake
- Reasonable insurance for most people on modern diets
Intermediate Protocol (multi-target use with specific clinical indication):
For individuals with specific conditions or goals where glycine has evidence-based application: type 2 diabetes, metabolic syndrome, aging biomarker improvement, post-surgical recovery, specific sleep disorders, or connective tissue priorities.
Month 1 (establishment):
- Begin at 5 g twice daily (total 10 g), morning and evening with meals.
- Monitor subjective response: sleep quality, energy, GI tolerance, any cardiovascular effects.
- If targeting aging/glutathione specifically: add NAC 600 mg twice daily (total 1200 mg).
- Obtain baseline labs relevant to indication: HbA1c if diabetic, hsCRP for inflammation, any other relevant markers.
Month 2-3 (consolidation):
- Continue 10 g daily (or titrate up to 15 g if needed for specific indication).
- Reassess at 3-month mark:
- Sleep: subjective improvement?
- Glycemic: HbA1c change vs baseline?
- Energy and physical function (particularly important in older adults)?
- Any adverse effects?
- If no objective or subjective improvement at 3 months, consider discontinuing or reassessing approach.
Month 4-6 (optimization):
- For responders, continue at established dose.
- Consider stack optimization:
- Add creatine 5 g if not already supplementing
- Add taurine 2-3 g for complementary effects
- Ensure magnesium, vitamin D, omega-3 foundational adequacy
- Long-term use at 5-10 g daily is well-tolerated and well-supported.
Specific conditions and protocols:
For type 2 diabetes (adjunctive, under physician care):
- Glycine 5 g three times daily with meals (total 15 g)
- Duration: 3-month trial minimum for glycemic effect
- Continue standard antidiabetic medications; adjust only under physician direction
- Track: HbA1c at baseline and 3 months, fasting and post-prandial glucose
For metabolic syndrome:
- Glycine 5 g twice daily (10 g total)
- Combined with dietary and exercise interventions
- 3-6 month reassessment
For aging biomarkers (pre-GlyNAC intermediate):
- Glycine 5 g morning + 5 g evening (10 g total)
- Consider adding NAC 600 mg twice daily
- 3-6 month trial with biomarker reassessment
For chronic sleep issues (moderate severity):
- Glycine 5-10 g at bedtime (can split with 3 g at 30 min pre-bed + 5 g right before bed)
- Combined with sleep hygiene and magnesium glycinate
- Consider pairing with melatonin 0.5-3 mg for circadian support
For connective tissue priority (athletes, aging, skin):
- Glycine 10 g daily (split doses)
- Collagen peptides 20 g daily
- Vitamin C 1000 mg daily
- 3-6 month trial with skin, joint, or recovery assessment
For post-surgical or stress recovery:
- Glycine 5-10 g daily
- NAC 1200 mg daily
- Vitamin C 1000-2000 mg daily
- Continue during stress period and for 4-8 weeks after
For CKD adjunctive (under nephrology supervision):
- Glycine 3-5 g daily starting dose
- Dose adjustment based on kidney function
- Monitor serum creatinine, BUN, inflammatory markers
Advanced Protocol (high-dose clinical applications with specialist oversight):
These protocols involve higher doses or specific combination therapies. Most require physician oversight for the underlying condition.
Full GlyNAC protocol for aging biomarkers (per Sekhar/Kumar research):
- Glycine: 100 mg/kg body weight daily (for a 70-kg adult, ~7 g; for 90-kg adult, ~9 g)
- NAC: 100 mg/kg body weight daily (for a 70-kg adult, ~7 g NAC; clinically often 1200 mg BID)
- Total duration: 16 weeks to 6+ months for biomarker improvement
- Assessment: glutathione levels, mitochondrial function markers, inflammatory markers, body composition, physical performance (walking speed, grip strength)
- Practical dosing: Morning 3-5 g glycine + 600 mg NAC; Evening 3-5 g glycine + 600 mg NAC
- This is currently the best-documented glycine-based longevity intervention
Schizophrenia adjunctive treatment (under psychiatric care):
- Glycine 30-60 g daily divided TID or QID
- Duration: 8-12 week trial for negative symptom assessment
- Added to standard antipsychotic therapy; do not substitute
- Monitor: PANSS negative symptom scores, cognitive function, adverse effects
- Very high dose range requires supervision
High-dose for schizophrenia with clozapine:
- Glycine 15-30 g daily under psychiatric care
- Monitoring for any unusual adverse events
- Note: effects may be less robust when added to clozapine than other antipsychotics
Advanced connective tissue support (severe osteoarthritis, post-surgical joint recovery):
- Glycine 15-20 g daily (split doses)
- Collagen peptides 20-30 g daily
- Vitamin C 1000-2000 mg daily
- Proline 2-3 g daily
- 6-month trial with imaging/function assessment
Severe CKD under nephrology care:
- Individualized dosing based on kidney function
- Typically 3-10 g daily with dose reduction in advanced disease
- Monitor ammonia levels if concern about hepatic/renal handling
Severe insomnia with multiple failed interventions:
- Glycine 10-15 g at bedtime (higher than typical sleep dose)
- Combined with full sleep hygiene evaluation and treatment of any underlying causes
- Consider cognitive behavioral therapy for insomnia (CBT-I) as foundation
Hepatic support in advanced liver disease (under hepatology care):
- Glycine 3-10 g daily (dose limited by ammonia concerns in encephalopathy)
- Specialist monitoring for ammonia and mental status
- Not a substitute for standard hepatology care
Critical considerations for advanced protocols:
Laboratory monitoring:
- Baseline: CBC, comprehensive metabolic panel, liver function, kidney function, HbA1c if diabetic, lipid panel, inflammatory markers (hsCRP, ferritin), ammonia if liver disease
- 3-month: repeat relevant panels
- 6-month: repeat and assess response
- Annual thereafter for chronic users
Monitoring for specific clinical applications:
- GlyNAC: glutathione levels (if accessible), exhaled breath analysis markers (research setting), physical function assessments
- Schizophrenia: PANSS scores, cognitive testing, antipsychotic drug levels if applicable
- Diabetes: HbA1c, fasting glucose, glucose variability
- Connective tissue: joint function scales, skin elasticity measures, imaging as appropriate
Drug interactions to review at higher doses:
- Clozapine, olanzapine, other strong antipsychotics—generally compatible but monitor
- Benzodiazepines, barbiturates—additive sedation at higher doses
- Insulin, sulfonylureas—monitor for additive glucose reduction
- Advanced liver disease medications—ammonia concerns
Pregnancy considerations:
- Standard doses (3-10 g) considered safe during pregnancy
- High-dose protocols (>15 g) should be held during pregnancy unless specifically prescribed
- GlyNAC protocol: insufficient data on high-dose during pregnancy; discuss with obstetrics
Surgical considerations:
- No clear requirement to hold glycine before surgery given clean pharmacology
- Some surgeons prefer discontinuation of most non-essential supplements 1-2 weeks preoperatively as general policy
- Post-surgical resumption after GI function restored is reasonable
Renal adjustments:
- CrCl >60: no adjustment needed
- CrCl 30-60: monitor; may not need adjustment
- CrCl <30: reduce dose; specialist consultation
- Dialysis: specialist input required; glycine handling altered
Hepatic adjustments:
- Compensated cirrhosis: no specific adjustment; may be beneficial
- Hepatic encephalopathy or ammonia elevation: avoid or reduce significantly
- Urea cycle disorders: contraindicated without specialist guidance
Discontinuation considerations:
- No physiological withdrawal expected
- Tissue effects (glutathione, collagen) may persist for weeks after discontinuation then gradually decline
- Can be restarted at any time without taper or loading
- Abrupt discontinuation is acceptable
The fundamental principle for advanced glycine use: Higher doses do not automatically produce proportionally greater benefits. For most users, 5-10 g daily captures the majority of documented benefits. Higher doses are appropriate for specific evidence-based indications (schizophrenia, GlyNAC protocols) or when addressing significant tissue-level deficits, but should be undertaken with monitoring and realistic expectations. Glycine is one of the safest compounds in foundational supplementation, but any intervention benefits from thoughtful protocol design.
Commonly Stacked With
Glycine stacks exceptionally well with many foundational supplements and nutraceutical compounds. The combinations below have specific mechanistic rationale and/or clinical trial support.
N-acetylcysteine (NAC) pairing — the GlyNAC protocol: This is the most evidence-based glycine stack. Glycine plus NAC provides both substrates for glutathione synthesis (glycine and cysteine) that are frequently limiting in older adults. Dose: glycine 100 mg/kg (typically 7-10 g for adults) plus NAC 100 mg/kg (typically 1200 mg). Tested in Sekhar/Kumar trials showing improvements in oxidative stress, inflammation, mitochondrial function, insulin resistance, and physical function. Best taken with meals, split doses (morning and evening). Essential stack for healthy aging applications in adults over 60. See /compound/nac for NAC details.
Taurine complementarity: Glycine and taurine share some functions (organic osmolytes, inhibitory neurotransmission, bile acid conjugation) but through distinct mechanisms. Combined supplementation (glycine 3-5 g + taurine 2-3 g) provides complementary support. Both are sweet-tasting, inexpensive, and well-tolerated. Particularly useful in longevity stacks. See /compound/taurine.
Creatine synergy: Glycine is one of the precursors for endogenous creatine synthesis. Supplemental creatine bypasses this synthetic pathway. Combining both is complementary—creatine provides immediate phosphocreatine substrate, while glycine supports ongoing endogenous creatine synthesis plus its many other functions. Doses: creatine 5 g + glycine 3-10 g daily. Both are foundational for most users. See /compound/creatine.
Collagen peptides pairing: Collagen supplements provide complete collagen-precursor amino acids (glycine, proline, hydroxyproline, etc.) in specific ratios. Adding standalone glycine can be useful because collagen typically contains glycine at ~33% by residue count, meaning 10 g of collagen provides about 3 g glycine—often insufficient to meet total glycine requirements. Combined: 10-20 g collagen peptides + 3-5 g standalone glycine provides optimal connective tissue support. Take together with vitamin C (100-500 mg) for proline hydroxylation support.
Magnesium glycinate as a combined product: Magnesium glycinate is magnesium bisglycinate—magnesium ion bound to two glycine molecules. Provides both magnesium (for bone, muscle, sleep) and glycine (for the above functions). Typical dose: 200-400 mg elemental magnesium provides approximately 1.5-3 g glycine. For higher glycine doses, use standalone glycine. Magnesium glycinate is a common and well-tolerated form; glycine binding improves magnesium bioavailability. See /compound/magnesium.
Vitamin C for collagen synthesis: Vitamin C is required for the hydroxylation of proline and lysine residues in collagen—essential steps in collagen maturation. Glycine supplementation without adequate vitamin C will not optimize collagen synthesis. Ensure 500+ mg vitamin C daily, either from diet (citrus, peppers, berries) or supplementation. Especially important if using glycine specifically for connective tissue support.
B-vitamin complex interaction: Glycine metabolism via the glycine cleavage system requires vitamin B6, folate, and other cofactors. B-vitamin adequacy supports optimal glycine utilization. Standard B-complex or high-quality multivitamin covers this.
Magnesium (standalone) + glycine for sleep: Magnesium glycinate 200-400 mg plus additional glycine 3-5 g 30-60 minutes before bedtime is a potent sleep support combination. Magnesium supports GABA function and muscle relaxation; glycine supports temperature regulation and sleep onset. Both are well-tolerated. Add L-theanine 200 mg or melatonin 0.5-3 mg for additional sleep support in some individuals.
Vitamin D for metabolic integration: No direct interaction with glycine, but vitamin D adequacy supports many of the same systems that benefit from glycine (bone, immune, metabolic). Foundational co-supplementation. See /compound/vitamin-d.
Zinc and copper (foundational trace minerals): No direct interaction. Foundational stack. See /compound/zinc.
Omega-3 fatty acids: No direct interaction. Complementary cardiovascular and anti-inflammatory effects. See /compound/omega-3-fatty-acids.
NMN/NR (NAD+ precursors): Complementary longevity support. Both address different aspects of aging—glycine via glutathione restoration and protein synthesis, NAD+ precursors via sirtuin activation. Combined use reasonable for comprehensive longevity stacks. See /compound/nmn.
Alpha-ketoglutarate (AKG) and other longevity compounds: No direct interaction. Complementary approaches to longevity.
Metformin and berberine: No direct interaction; complementary glycemic effects. Glycine provides modest glucose reduction; metformin/berberine provides larger reductions through different mechanisms. See /compound/metformin.
Rapamycin: No direct interaction. Both target longevity through different mechanisms. Combined use reasonable for comprehensive stacks. See /compound/rapamycin.
Acetyl-L-carnitine: Both may support mitochondrial function and brain health through different mechanisms. No antagonism.
Coenzyme Q10: No direct interaction. Complementary mitochondrial support.
Proline and hydroxyproline (collagen precursors): Direct synergy for connective tissue applications. Combined glycine + proline + hydroxyproline + vitamin C provides optimal collagen synthesis substrate. Some supplements package these together for skin and joint support.
Lysine: Glycine and lysine are both required for collagen. Lysine tends to be adequate in typical diets but may be lower in some vegetarian patterns.
BCAAs (leucine, isoleucine, valine): No direct interaction with glycine. Complementary amino acid support for different purposes—BCAAs for muscle protein synthesis, glycine for connective tissue, neurotransmission, and glutathione.
L-theanine: Both have mild anxiolytic and sleep-supporting effects through different mechanisms. Combined (glycine 3 g + theanine 200 mg before bed) works well for some users.
Melatonin: Complementary sleep support. Glycine improves sleep quality; melatonin resets circadian rhythm. Combined: melatonin 0.5-3 mg + glycine 3-5 g at bedtime.
Cannabinoids (CBD, THC): No specific documented interactions. Both affect neurological function through different mechanisms.
5-HTP and tryptophan: Both are serotonin precursors. No direct interaction with glycine; complementary sleep/mood effects for some users.
Caffeine: No direct interaction. Glycine is not an effective counter-stimulant for excessive caffeine.
What to avoid or time carefully:
- Avoid very high-dose glycine (>30 g) with significant alcohol consumption (both affect CNS)
- Separate from bile acid sequestrants (cholestyramine, colesevelam) by 2 hours
- Time pre-workout vs bedtime glycine doses appropriately for your goals
- In patients on clozapine or other strong antipsychotics, discuss high-dose glycine with prescriber
Timing strategy:
Morning dosing: Supports daytime glutathione, energy, and cognitive function. 3-5 g with breakfast works well. Less sedation than bedtime dosing. Pairs naturally with NAC (GlyNAC protocol) morning dose.
Afternoon dosing: Optional mid-afternoon 3-5 g to sustain levels; useful for GlyNAC protocol as split second dose.
Evening/bedtime dosing: 3-10 g taken 30-60 minutes before bed supports sleep onset and early-night sleep quality through temperature regulation and mild sedation. Often paired with magnesium glycinate and optional L-theanine or melatonin.
Split dosing (for GlyNAC or longevity protocols): Morning 5 g + evening 5 g totaling 10 g daily is a common effective schedule. Alternatively, 3 times daily with meals for very high total doses.
Stack for sleep and recovery:
- Glycine 3-5 g bedtime
- Magnesium glycinate 200-400 mg bedtime
- L-theanine 200 mg bedtime (for some)
- Optional: melatonin 0.5-3 mg
Stack for aging and glutathione (GlyNAC protocol):
- Glycine 5 g twice daily (morning and evening)
- NAC 600 mg twice daily
- Vitamin C 500-1000 mg daily
- B-complex vitamin
Stack for connective tissue support:
- Glycine 5-10 g daily
- Collagen peptides 10-20 g daily
- Vitamin C 500-1000 mg daily
- Proline 1-2 g daily (optional)
Stack for glycemic support:
- Glycine 5 g with largest meals (2-3 times daily)
- Magnesium 400 mg daily
- Berberine or metformin per protocol
Stack for comprehensive longevity:
- Glycine 5 g morning + 5 g evening
- NAC 600 mg twice daily
- Taurine 2-3 g daily
- Creatine 5 g daily
- Omega-3 2-3 g daily
- Vitamin D 2000-5000 IU
- Magnesium glycinate 400 mg
Long-term monitoring: No specific lab monitoring required for most users. Consider glutathione levels and inflammatory markers (hsCRP) if tracking GlyNAC response. Standard comprehensive annual labs capture any relevant changes.
Side Effects & Safety
Contraindications
Glycine has one of the cleanest safety profiles among widely used supplements. Absolute contraindications are rare, and most situations requiring caution are relative rather than absolute. **Absolute contraindications:** - Known hypersensitivity to glycine or excipients in a specific product (extremely rare) - Urea cycle disorders (unless specifically prescribed by specialist)—glycine metabolism can contribute to ammonia load - Active severe hepatic encephalopathy with elevated ammonia **Strong relative contraindications (medical supervision recommended):** *Advanced liver disease (Child-Pugh C):* Glycine's contribution to ammonia production through the glycine cleavage system could theoretically worsen encephalopathy. Moderate doses may be acceptable under hepatology supervision. *Advanced chronic kidney disease / dialysis:* Altered amino acid handling; dose adjustment likely needed. Consult nephrology. *Acute schizophrenia or acute psychotic states:* Chronic high-dose glycine may benefit negative symptoms, but acute decompensated psychosis requires emergency psychiatric management, not supplement introduction. *Pregnancy with very high-dose protocols:* Standard doses (3-10 g) considered safe and even beneficial during pregnancy. High-dose protocols (>15 g) should be held or held pending obstetric input. *Trimethylglycine (TMG) / betaine naming confusion:* These are different compounds despite the naming. TMG is specifically contraindicated or requires caution in some settings (e.g., very high homocysteine levels without appropriate workup) that don't apply to plain glycine. **Situations requiring careful dose consideration:** *Older adults with polypharmacy:* Multiple drug interactions (minor but worth considering). Start at lower doses, monitor for sedation. *Patients with sleep apnea (untreated):* Glycine's mild sedative effects at higher bedtime doses could theoretically worsen sleep apnea symptoms. Treat underlying sleep apnea (CPAP) before considering glycine for sleep. *Patients on strong CNS depressants (benzodiazepines, opioids, barbiturates):* Mild additive sedation possible at higher doses. Consider morning dosing instead of bedtime, or reduce dose. *Type 1 diabetes:* Limited data specifically in T1D. Some potential for glycine's insulin-sensitizing effects. Monitor glucose if starting; discuss with endocrinology. *Established cardiovascular disease:* Generally well-tolerated; may offer modest benefits. No specific contraindications beyond standard supplement review. *Cancer (active treatment):* Complex considerations. Glycine supports glutathione (could reduce chemotherapy efficacy for some agents that rely on oxidative damage) or could support healthy cell function. Discuss with oncology team. *Autoimmune conditions:* Generally safe. Some theoretical interest for lupus, rheumatoid arthritis via anti-inflammatory mechanisms; evidence is limited. **Drug interactions requiring attention:** *Antipsychotic medications:* Glycine has been safely combined with most antipsychotics in schizophrenia trials. Clozapine combinations have been less robustly beneficial but not harmful. Discuss with psychiatry. *Benzodiazepines and barbiturates:* Mild additive CNS depression at higher glycine doses. Usually well-tolerated. *Opioid medications:* Possible additive sedation. Usually not clinically significant at standard glycine doses. *Alcohol:* No specific interaction but both affect CNS and liver. Moderate use of both is acceptable; avoid combining very high doses. *Bile acid sequestrants (cholestyramine, colesevelam):* May theoretically reduce glycine absorption. Separate by 2 hours. *Insulin and oral antidiabetics:* Potential for additive glucose reduction. Monitor glucose when starting glycine in tightly-controlled diabetics. *Levodopa and Parkinson's medications:* Large neutral amino acids compete for blood-brain barrier transport. Theoretically, very high glycine doses could affect levodopa absorption, but clinical significance is typically minimal. *Tricyclic antidepressants:* No documented specific interactions. *SSRIs and SNRIs:* No documented specific interactions. *NMDA modulators (memantine, ketamine):* Glycine is a co-agonist at NMDA receptors. Theoretical interactions; clinical significance unclear. Discuss with prescriber. *Diuretics:* No documented specific interactions. *ACE inhibitors and ARBs:* No documented specific interactions. *Statins:* No documented specific interactions. **Situations where glycine supplementation is NOT recommended:** *As a substitute for medical treatment:* Glycine is an adjunctive supplement, not a replacement for prescribed medications for serious conditions (diabetes, schizophrenia, kidney disease). *Very young children without specific medical indication:* Infant formula contains glycine; pediatric supplementation beyond that is not evidence-based without specialist input. *Acute decompensated liver disease with elevated ammonia:* Avoid until ammonia levels stable and specialist guidance available. *Urea cycle disorders:* Avoid unless specifically prescribed as part of disorder management. **When to stop glycine supplementation:** Immediate discontinuation warranted for: - Unexpected severe GI symptoms not responsive to dose reduction - Excessive sedation interfering with daily function - Elevated ammonia or signs of hepatic decompensation in patients with liver disease - Development of new serious medical conditions that may affect amino acid handling - Pregnancy with doses above 15 g daily unless specifically prescribed Gradual reduction reasonable for: - Resolution of original indication - Desire to reduce supplement burden - Shift to dietary adequacy (increased dietary collagen, bone broth, etc.) - Cost considerations **Monitoring recommendations by use case:** *Foundational daily (3-10 g):* No specific monitoring beyond annual complete health assessment. *GlyNAC protocol (10 g + NAC):* Baseline and 3-6 month labs for response assessment: glutathione (if available), inflammatory markers (hsCRP), metabolic panel, physical function. *High-dose therapeutic (>15 g chronically):* Monitoring specific to indication. Liver function periodically if prolonged high-dose use. *Schizophrenia adjunctive (30-60 g):* Psychiatric monitoring. Occasional labs for metabolic function. **Pre-surgical considerations:** Not typically required to hold glycine before surgery given clean pharmacology profile. Discuss with surgical team; some surgeons prefer discontinuation of most non-essential supplements 1-2 weeks preoperatively. Post-surgical resumption after GI function restored. **Dose adjustments:** *Renal impairment:* - CrCl >60: no adjustment - CrCl 30-60: monitor; consider reduction if any symptoms - CrCl <30: reduce dose; specialist consultation - Dialysis: specialist input required *Hepatic impairment:* - Compensated cirrhosis: no specific adjustment; potentially beneficial - Decompensated cirrhosis/encephalopathy: avoid or very careful specialist-supervised use - Mild-moderate hepatitis: no specific adjustment *Elderly:* - Generally no specific adjustment - May be particularly responsive to GlyNAC protocol benefits - Monitor for sedation effects, particularly with bedtime dosing *Pediatric:* - Infant formula contains glycine naturally - Beyond formula, pediatric dosing should be specialist-directed - Not recommended for routine pediatric use without clinical indication **Counseling points for new users:** - Expect subtle effects over weeks; glycine is not a rapid-acting supplement for most indications - Sleep effects may be noticeable within days for some users - Connective tissue effects take months of consistent use - GlyNAC protocol effects on biomarkers typically evident at 3-6 months - Higher doses are not necessarily better; most users do well at 3-10 g daily - Combine with NAC for glutathione-focused applications - Combine with collagen for connective tissue focus - Safety profile is excellent; adjust based on tolerance and response
Additional Notes
Glycine dosing is expressed directly as elemental glycine (no conversion factor—1 g glycine = 1 g glycine, unlike mineral salts where elemental content varies).
Commonly used glycine doses by indication:
Foundational wellness and dietary supplementation:
- 3-5 g daily
- Covers baseline gap between typical intake and functional requirement
Sleep support:
- 3 g at bedtime (standard tested dose)
- 5-10 g at bedtime for more pronounced effect
GlyNAC protocol (aging biomarkers):
- 100 mg/kg body weight glycine (typically 7-10 g)
- Plus 100 mg/kg NAC (typically 1200 mg clinical dose)
- Split doses morning and evening
Type 2 diabetes adjunctive:
- 5 g with meals, 2-3 times daily (10-15 g total)
Metabolic syndrome:
- 5 g twice daily (10 g total)
Connective tissue support:
- 5-10 g daily
- Often combined with collagen peptides
Schizophrenia adjunctive:
- 30-60 g daily (divided doses)
- Under psychiatric supervision
Post-surgical recovery:
- 5-10 g daily
- Combined with NAC and vitamin C
Vegetarian/vegan dietary supplementation:
- 3-5 g daily to compensate for low dietary collagen/connective tissue intake
Upper tested doses:
- 60 g daily has been used safely in schizophrenia trials
- EU/US safety assessments consider the amounts used in clinical trials acceptable
- For most general users, doses above 15 g daily are unnecessary
Timing and food considerations:
With food: Slightly reduces absorption rate but improves GI tolerance. Standard for most users.
Empty stomach: Faster absorption, slightly higher peak concentrations. Higher GI upset risk. Useful for sleep dosing (empty stomach before bed).
Split dosing: For total daily doses above 5 g, splitting into 2-3 portions improves both absorption and tolerance.
Morning vs evening:
- Morning: supports daytime glutathione, energy, one-carbon metabolism. Pair with NAC for full GlyNAC effect.
- Evening: supports sleep and overnight recovery.
- Split: combines both benefits for total doses ≥5 g daily.
Powder vs capsule forms:
Powder (most common for higher doses):
- Pros: Cost-effective, flexible dosing, easy to mix into liquid
- Cons: Requires measuring (scoop or scale)
- Taste: Pleasantly sweet (about 70% as sweet as sucrose)
- Best for: Anyone taking >3 g daily, budget-conscious users
- Measuring: 1 level teaspoon ≈ 4 g; 1/2 teaspoon ≈ 2 g. For precise dosing, use digital kitchen scale.
Capsules:
- Pros: Convenient, precise dosing, no taste issues, travel-friendly
- Cons: Many capsules needed for doses >3 g (typical 500 mg-1 g per capsule)
- Best for: Lower doses, convenience focus, travel
Liquid:
- Less common; may include flavoring
- Reasonable for pediatric or geriatric use with difficulty swallowing
Storage:
- Room temperature, dry location
- Very stable compound; not sensitive to light, air, or moderate humidity
- Powder may clump slightly with moisture exposure but potency remains intact
- Shelf life: typically 3-5 years in original packaging
- Refrigeration not necessary
Quality considerations:
Pharmaceutical-grade vs supplement-grade:
- Pharmaceutical-grade USP-NF: highest purity, used in research trials
- Supplement-grade (USP or equivalent): typically >99% pure, sufficient for consumer use
- Third-party testing (USP, NSF, Informed Choice, Clean Label Project) adds quality assurance
Source:
- Most commercial glycine is produced via chemical synthesis (typically from chloroacetic acid and ammonia, or from Strecker synthesis)
- Vegan/vegetarian appropriate regardless of manufacturing route
- Some older products used animal-sourced glycine (from collagen hydrolysis); uncommon today
Country of origin:
- Widely produced; quality varies by manufacturer rather than country
- Reputable brands source from facilities with appropriate quality control
What to look for on supplement labels:
- Glycine content clearly stated (per capsule or per serving)
- Quality certifications (USP, NSF, Informed Choice)
- Absence of unnecessary fillers/additives (pure glycine is preferable)
- Third-party testing documentation available
Distinguishing products:
Glycine vs glycinate:
- Glycine = free amino acid
- Glycinate = bound form (e.g., magnesium glycinate = Mg bound to 2 glycines)
- Magnesium glycinate 200 mg elemental magnesium provides ~1.5 g glycine
- For standalone glycine benefits, use pure glycine; for combined mineral+glycine, use glycinate forms
Glycine vs glycan/glycol:
- Glycine = amino acid (aminoacetic acid)
- Glycan = general term for carbohydrate polymer
- Glycol = class of organic compounds (ethylene glycol, propylene glycol—NOT related)
- Commercial mislabeling is rare but possible; verify specifically for "glycine"
Glycine vs TMG (trimethylglycine, betaine):
- Different molecules despite naming similarity
- TMG = N,N,N-trimethylglycine; used for homocysteine reduction and methylation support
- Glycine and TMG have related but distinct applications
- Both are foundational but not interchangeable
Combination products:
GlyNAC (glycine + NAC) combination supplements:
- Increasingly available as pre-made combination products
- Doses vary; many provide lower NAC than research protocols used
- Reading labels carefully is important
Magnesium glycinate:
- Popular magnesium form providing both magnesium and glycine
- Dose 200-400 mg elemental magnesium provides 1.5-3 g glycine
- Not sufficient for users wanting >5 g glycine; supplement with standalone glycine
Sleep formulas with glycine:
- Many sleep stacks include 1-3 g glycine plus other agents (magnesium, theanine, melatonin)
- Reasonable for sleep focus; single-compound supplements provide more flexibility
Collagen + glycine combinations:
- Collagen peptides naturally contain ~33% glycine
- Adding standalone glycine to collagen boosts total glycine intake
- Common combination for connective tissue focus
Overdose and missed doses:
- Missed single daily dose: resume normal schedule; no need to double up
- Missed multiple days: resume normal schedule; tissue glycine stores are buffered
- Accidental higher-than-intended dose (up to 30 g single dose): expect mild GI upset and possible sedation, self-limited
- No known acute toxic dose in adults
- Contact poison control for symptomatic overdose, though rare at any practical dose
Monitoring during chronic use:
- Standard annual comprehensive labs capture any changes
- No specific glycine-level monitoring required
- Glutathione levels helpful for GlyNAC protocol response tracking (availability limited to research or specialty labs)
- Clinical parameters relevant to the indication (HbA1c for diabetes, inflammatory markers for aging protocols)
Frequently Asked Questions
What is the recommended Glycine dosage?
Dosage for Glycine varies by protocol. Consult a qualified healthcare provider.
How often should I take Glycine?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Glycine need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Glycine side effects?
Glycine has an exceptional safety profile across extensive clinical use. Doses up to 60 g daily have been used in schizophrenia trials without systematic serious adverse effects. For typical supplementation doses (3-15 g daily), side effects are uncommon and generally mild. **Common mild side effects (typically at higher doses):** - **Gastrointestinal discomfort:** Mild nausea or loose stools occur in a small percentage of users, particularly with doses above 15 g taken without food. Usually resolves with dose reduction, splitting doses, or taking with food. - **Soft stools or mild diarrhea:** May occur at higher doses, particularly when starting at full dose rather than titrating up. - **Mild sedation:** Dose-dependent; typical at bedtime doses of 3-10 g. Desirable for sleep applications but may be undesirable for daytime use in some individuals. - **Dream intensity changes:** Some users report more vivid or memorable dreams at bedtime doses. Generally neutral to positive but can be disconcerting for some. - **Sweet taste:** Glycine has a naturally sweet taste (about 70% the sweetness of sucrose). This is the "side effect" of the compound's organoleptic properties rather than a true adverse effect. **Uncommon side effects:** - **Morning grogginess:** Possible at higher bedtime doses (>10 g) in sensitive individuals. - **Lightheadedness:** Rare; may relate to peripheral vasodilation (the same mechanism responsible for glycine's pre-sleep temperature reduction). - **Headache:** Occasional reports; unclear mechanism. - **Mild ammonia elevation:** Glycine is metabolized partially by the glycine cleavage system producing ammonia. In patients with advanced liver disease or urea cycle disorders, this could theoretically be problematic. Generally not clinically relevant in healthy individuals. **Rare but notable concerns:** *Schizophrenia adjunctive use — very high doses:* Doses of 30-60 g daily used in schizophrenia trials have been associated with occasional GI symptoms, mild edema, and sedation. Most trials have completed without serious adverse effects. These extreme doses are not applicable to general consumer supplementation. *GlyNAC protocol specific considerations:* Combining glycine ~10 g with NAC ~1200 mg daily (per Sekhar protocols) has been well tolerated in older adults. Minor GI symptoms are the most common issue. Some patients experience initial fatigue that typically resolves within 1-2 weeks. *Perioperative use:* Glycine has been used safely in perioperative protocols. No specific anesthetic interactions documented, but discussion with surgical team is appropriate as with all supplements. **Theoretical concerns:** *NMDA receptor activation:* While glycine is a co-agonist at NMDA receptors (requiring glutamate for activation), excessive activation could theoretically contribute to excitotoxicity in settings of brain ischemia or trauma. Clinical evidence of harm is absent. This concern is largely theoretical in physiological states. *Cancer cell proliferation:* Glycine is required for rapid cell division including tumor cell growth. Some evidence suggests glycine supplementation could hypothetically support cancer cell proliferation in established cancer. Clinical implications are unclear; cancer patients should discuss with oncology team. *Bipolar disorder:* Limited evidence regarding effects on mood cycling in bipolar disorder. Theoretical concern about NMDA receptor modulation and mood; not a documented clinical issue. *Homocysteine metabolism:* Glycine participates in one-carbon metabolism. Very high doses in patients with MTHFR polymorphisms or B-vitamin deficiencies could theoretically affect homocysteine levels, though this has not been a documented clinical issue. *Trimethylglycine (TMG, betaine) interaction:* Not a concern; these are different compounds despite the naming similarity. TMG is N,N,N-trimethylglycine, distinct from plain glycine. *Liver conditions:* Patients with advanced hepatic encephalopathy or urea cycle disorders may have impaired ammonia handling. Discuss with hepatology before high-dose glycine. **Drug interactions:** *Clozapine and other strong antipsychotics:* Combined use with high-dose glycine has been done in schizophrenia trials without systematic problems. Caution with clozapine because of its own pharmacological complexity. *Strychnine:* Glycine receptor antagonism is the mechanism of strychnine toxicity. Glycine would not reverse strychnine poisoning but obviously this is not a practical concern. *Benzodiazepines and CNS depressants:* Mild additive sedation possible at higher glycine doses. Usually well tolerated. *Alcohol:* No specific interaction, but both affect CNS function. Avoid combining very high-dose glycine with substantial alcohol. *Sodium valproate and other anticonvulsants:* No documented interactions, but glycine's NMDA effects could theoretically interact with anticonvulsant mechanisms. Discuss with neurology if on seizure medications. *Isotretinoin and other hepatotoxic drugs:* No specific interaction; glycine supports hepatic detoxification. *Methadone and opioid replacement therapy:* No documented interaction. *Bile acid sequestrants:* Theoretical reduction in absorption; separate by 2 hours. *Levodopa and Parkinson medications:* No documented interactions. **Populations requiring caution:** *Pregnancy and lactation:* Glycine is naturally present in breast milk and is important for fetal development. Supplementation within typical ranges (3-10 g daily) is considered safe during pregnancy and lactation. Higher doses (>15 g) should only be used with obstetric input. *Pediatrics:* Infant formula contains glycine naturally. Pediatric supplementation beyond that is not routine; should be guided by pediatric specialists. *Advanced liver disease:* Particularly in hepatic encephalopathy, glycine metabolism may be altered. Discuss with hepatology before supplementation. *Advanced kidney disease:* Generally well tolerated; dose adjustment may be appropriate in very advanced disease or dialysis. *Urea cycle disorders:* Contraindicated or requires specialist management due to ammonia handling concerns. *Schizoaffective or psychotic disorders:* Paradoxically, glycine may benefit negative symptoms (as tested in schizophrenia), but could theoretically affect acute psychosis. Use under psychiatric supervision. **Signs to monitor:** - GI symptoms at initiation—if persistent despite dose reduction and food co-administration, consider discontinuation - Excessive sedation (reduce bedtime dose or move to different timing) - Any neurological changes (uncommon but worth noting) - Blood sugar changes if diabetic (mild glucose reduction expected; significant changes may require medication adjustment) **When to reduce or discontinue:** - Persistent GI discomfort despite food co-administration and dose reduction - Excessive morning grogginess - Unwanted changes in dream quality or vividness - Pregnancy with doses above 15 g daily unless specifically prescribed - Development of new medical conditions that affect amino acid handling **Withdrawal considerations:** No physiological withdrawal syndrome has been documented with glycine discontinuation. Benefits (sleep, glutathione status, collagen synthesis support) may gradually decline over weeks after stopping, but there is no acute withdrawal. No need to taper. **Quality and contamination concerns:** - Pharmaceutical-grade and food-grade glycine are well-regulated - Purity is typically high (>99%) for reputable manufacturers - Rare reports of contamination with other amino acids or fillers in discount products - Third-party testing (USP, NSF) provides additional quality assurance
Where can I buy Glycine?
Visit our vendor directory to find trusted sources for Glycine.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
